Medicare released its next target list of 15 drugs to negotiate prices of, including Novo Nordisk's blockbuster GLP-1 drugs.

Former President Biden’s secretary of Health and Human Services is strongly considering running for governor of California, ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

The CMS said that the 23.6 million sign-ups to ... not over yet," Department of Health and Human Services Secretary Xavier Becerra said in the release. "The Affordable Care Act health insurance ...

CMS had until Feb. 1 to announce the new batch of drugs chosen ... Health and Human Services Secretary Xavier Becerra called the announcement a “great way to close out the four-year term of the ...

The U.S. Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), has selected 15 additional drugs for pr ...

The new tool on CMS.gov aims to streamline the complaint ... Health and Human Services (HHS) Secretary Xavier Becerra ...

BECERRA’S FINAL ACT — During the unveiling of his official portrait on Tuesday, HHS Secretary Xavier Becerra ... is returning as CMS chief operating officer. — Drew Snyder is expected ...

CMS has selected 15 new drugs for the next round of Medicare Part D price negotiations, according to a press release from HHS ...

However, the CMS is encouraging individuals to revisit ... costing $10 or less per month after tax credits. HHS Secretary Xavier Becerra emphasized the importance of continued participation ...

Novo NOrdisk (NVO) stock drops as Medicare selects 15 additional Part D drugs including its weight loss drug Wegovy for pricing negotiations. Read more here.

Even CMS’s projected cost to Medicare of $550 ... In 2022, Department of Health and Human Services Secretary Xavier Becerra announced that Medicare Part B premiums paid by Medicare beneficiaries ...